+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
SUPRIYA

Supriya Lifescience Share Price

₹923.45 +32.6 (3.66%)
69.29% Gain from 52W Low

07 Aug, 2026 3:56 PM (IST)

Supriya Lifescience live price: ₹923.45. It opened at ₹892 vs previous close ₹891; intraday high/low: ₹928/₹892. The 50 & 200 DMA stand at ₹862.60/₹769.60.

Supriya Lifescience Performance

  • Today's Low
  • ₹892
  • Today's High
  • ₹928
  • 52 Week Low
  • ₹546
  • 52 Week High
  • ₹1,085
  • Open Price₹892
  • Previous Close₹891
  • Volume247,031
  • 50 DMA₹862.60
  • 100 DMA₹818.60
  • 200 DMA₹769.60

Supriya Lifescience Chart

Investment Returns

  • Over 1 Month + 7.17%
  • Over 3 Month + 30.67%
  • Over 6 Month + 37.98%
  • Over 1 Year + 40.4%

Smart Investing Starts Here Start SIP with Supriya Lifescience for Steady Growth!

Invest Now

Supriya Lifescience Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 35.5
  • PEG Ratio
  • 3.2
  • Market Cap Cr
  • 7,432
  • P/B Ratio
  • 6.2
  • Average True Range
  • 38.1
  • EPS
  • 26
  • Dividend Yield
  • 0.1
  • MACD Signal
  • 4.3
  • RSI
  • 59.39
  • MFI
  • 75.1

Latest Stock News Updates

Supriya Lifescience Ltd - 543434 - Board Meeting Intimation for Unaudited Financial Results For Quarter Ended June 2026

Supriya Lifescience Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and approve In terms of Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this to inform you that a meeting of the Board of Directors of the Company will be held on Thursday, August 13, 2026, inter alia to consider and approve the Unaudited Financial Results of the Company for the quarter ended June 30, 2026. This is to further inform you that in accordance with the Company's Code of Conduct for Prevention of Insider Trading, the ''Trading Window' for dealing in the securities of the Company by Designated Persons and their immediate relatives is closed from July 1, 2026, till 48 hours after declaration of Unaudited Financial Results on August 13, 2026.

Supriya Lifescience Ltd - 543434 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Please find attached copy of Newspaper Publication of Postal Ballot Notice.

Supriya Lifescience Ltd - 543434 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot

Please Find Attached Postal Ballot Notice of Supriya Lifescience Limited.

Supriya Lifescience Financials

Supriya Lifescience Technicals

EMA & SMA

Current Price
₹923.45
+ 32.6 (3.66%)
pointer
  • Bearish Moving Average 0
  • Bullish Moving Average 16
  • 20 Day
  • ₹878.00
  • 50 Day
  • ₹862.60
  • 100 Day
  • ₹818.60
  • 200 Day
  • ₹769.60

Resistance and Support

914.38 Pivot Speed
  • R3 973.40
  • R2 950.70
  • R1 937.10
  • S1 900.80
  • S2 878.10
  • S3 864.50

Supriya Lifescience Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-08-13 Quarterly Results
2026-05-27 Audited Results & Final Dividend
2026-02-09 Quarterly Results
2025-11-12 Quarterly Results
2025-08-13 Quarterly Results
Date Purpose Remarks
2025-09-05 FINAL Rs.1.00 per share(50%)Final Dividend
View Supriya Lifescience Dividend History Arrow

Supriya Lifescience Shareholding Pattern

68.3%
20.21%
6.18%
4.01%
1.29%

Supriya Lifescience FAQs

Supriya Lifescience share price is ₹923 As on 09 August, 2026 | 23:20

The Market Cap of Supriya Lifescience is ₹7432.2 Cr As on 09 August, 2026 | 23:20

The P/E ratio of Supriya Lifescience is 35.5 As on 09 August, 2026 | 23:20

The PB ratio of Supriya Lifescience is 6.2 As on 09 August, 2026 | 23:20

The 52 week High & Low of Supriya Lifescience is ₹1085/₹545.5 respectively As on 09 August, 2026 | 23:20

Open FREE Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23